Skip to main content

Table 2 Hemodialysis patients’ demographic profiles, hemodialysis backgrounds, levofloxacin concentrations, and protein binding ratios

From: No effect of protein binding ratio of levofloxacin in hemodialysis patients

Patient no.

Age (years)

Sex

DW (kg)

SAr (m2)

DM

BFR (mL/min)

TT (h)

BST (h)

SP (g/dL)

SA (g/dL)

SG (g/dL)

LVFX (mg/L)

PBR (%)

1

52

Male

96.0

2.2

PS

250

5

Just before HD

6.9

3.9

3.0

4.0

30.9

2

88

Male

48.7

0.9

CTA

160

3

Just before HD

6.0

3.6

3.9

34.5

3

82

Male

51.5

1.1

PES

160

4

Non-HD days

5.0

2.8

2.2

7.6

29.6

4

62

Male

64.0

1.9

PES

220

4

Just before HD

6.4

3.2

3.1

1.9

20.0

5

91

Male

47.5

1.1

PES

180

4

Just before HD

6.5

2.7

3.6

7.3

23.7

6

77

Male

55.8

1.9

PES

200

4

Non-HD days

6.4

3.9

2.5

6.5

36.8

Average

75.3

 

60.6

1.5

 

195.0

4.0

 

6.2

3.4

2.9

5.2

29.3

SD

15.3

 

18.4

0.5

 

35.6

0.6

 

0.7

0.5

0.5

2.3

6.4

  1. SD standard deviation, DW dry weight, SAr surface area, DM dialyzer membrane, BFR blood flow rate, TT treatment time, BST blood sampling time after administration of levofloxacin, SP serum protein, SA serum albumin, SG serum globulin, LVFX serum levofloxacin concentration, PBR protein binding ratio, HD hemodialysis, PS polysulfone, CTA cellulose triacetate, PES polyether sulfone